Skip to main content

HighRes® and Waters Collaborate to Advance Drug Discovery through Robotic Automation

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

 

HighRes® today announced a strategic collaboration to enable robotic capabilities on Waters Biosciences, formerly BD Biosciences, flow cytometers to automate key experimental steps and streamline research workflows, from basic research to drug discovery.

The companies are integrating the BD FACSLyric™ Flow Cytometer1 with the HighRes Nucleus® Automation and Cellario® Software Platforms, enabling scientists to utilize robotic arm capabilities to run reliable, complex, multi-step experiments unattended with continuous operation of up to three times more experimental runs per day. The integration enables higher-throughput studies, improves reproducibility, and allows for greater operational efficiency.

"The BD FACSLyric™ Flow Cytometer, when paired with HighRes automation, is an ideal solution for laboratories running complex flow cytometry studies that demand scale and precision, including for higher volumes of experiments," said Eric Diebold, Vice President and General Manager, Instruments & informatics, Waters Biosciences, Waters Corporation. "This collaboration exemplifies our long-term commitment to advancing robotic automation across our complete portfolio of flow cytometers, unlocking a new dimension of automation for research and biopharma partners aiming to bring their potentially life-changing therapies to market even faster.”

“With this collaboration, scientists can run more experiments per day with consistent quality, reduce hands-on time from hours to minutes, and design assays that were previously too complex or time-sensitive to automate – with every step tracked for complete data integrity and reproducibility,” said Ira Hoffman, CEO, HighRes. “By combining BD’s expertise in flow cytometry and HighRes’ leadership in lab automation, we are enabling more labs around the world to operate with true end-to-end confidence.”

Labs interested in deploying the BD FACSLyric™ with HighRes automation can schedule a consultation today. More information can be found at highres.com.

About HighRes

HighRes partners with life science organizations to implement intelligent data and lab automation workflows that empower every team member to plan and execute efficient and reproducible science. Visit our website to learn more at highres.com.

1 RUO disclaimer for US: BD FACSLyric™ Flow Cytometers are Class 1 Laser Products. The BD FACSLyric™ Flow Cytometer is For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.27
+0.16 (0.07%)
AAPL  293.08
-1.22 (-0.41%)
AMD  519.74
-0.11 (-0.02%)
BAC  57.73
-0.18 (-0.31%)
GOOG  345.04
-1.04 (-0.30%)
META  557.67
-4.53 (-0.81%)
MSFT  365.46
-8.48 (-2.27%)
NVDA  199.00
-1.04 (-0.52%)
ORCL  157.53
-7.63 (-4.62%)
TSLA  375.53
-6.08 (-1.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.